Philippine FDA shortens COVID-19 booster interval to three months
The Philippine Food and Drug Administration approved a reduction in the interval for COVID-19 booster doses to three months for those who completed a two-dose primary series, and two months for those who received a single-dose vaccine, to address variant transmission.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthPhilippine FDA shortens COVID-19 booster interval to three months
Sign in or subscribeBrowse free archive reportsThe Philippine Food and Drug Administration approved a reduction in the interval for COVID-19 booster doses to three months for those who completed a two-dose primary series, and two months for those who received a single-dose vaccine, to address variant transmission.